BRPI0713561A2 - composto ou um sal ou pró-droga farmaceuticamente aceitável do mesmo, composição, e, métodos de modulação do receptor e de tratamento de uma doença - Google Patents

composto ou um sal ou pró-droga farmaceuticamente aceitável do mesmo, composição, e, métodos de modulação do receptor e de tratamento de uma doença Download PDF

Info

Publication number: BRPI0713561A2
Authority: BR; Brazil
Prior art keywords: methods; pharmaceutically acceptable; disease; compound; composition
Prior art date: 2006-06-23

Application number

BRPI0713561-0A

Other languages

English (en)

Portuguese (pt)

Inventor

Metcalf Brian

Zhang Ke

Zheng Changsheng

Xue Chu-Biao

Cao Ganfeng

Wang Anlai

Original Assignee

Incyte Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-23

Filing date

2007-06-22

Publication date

2012-03-13

2007-06-22 Application filed by Incyte Corporation filed Critical Incyte Corporation

2007-06-22 Priority claimed from PCT/US2007/071895 external-priority patent/WO2007150026A2/en

2012-03-13 Publication of BRPI0713561A2 publication Critical patent/BRPI0713561A2/pt

Links

150000001875 compounds Chemical class 0.000 title abstract 3
201000010099 disease Diseases 0.000 title abstract 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
150000003839 salts Chemical class 0.000 title abstract 3
229940002612 prodrug Drugs 0.000 title 1
239000000651 prodrug Substances 0.000 title 1
UFZNZKGKBWOSJG-UHFFFAOYSA-N purin-2-one Chemical class O=C1N=CC2=NC=NC2=N1 UFZNZKGKBWOSJG-UHFFFAOYSA-N 0.000 abstract 1
239000000018 receptor agonist Substances 0.000 abstract 1
229940044601 receptor agonist Drugs 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

BRPI0713561-0A 2006-06-23 2007-06-22 composto ou um sal ou pró-droga farmaceuticamente aceitável do mesmo, composição, e, métodos de modulação do receptor e de tratamento de uma doença BRPI0713561A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US81593506P	2006-06-23	2006-06-23
US60/815935		2006-06-23
PCT/US2007/071895 WO2007150026A2 (en)	2006-06-23	2007-06-22	Purinone derivatives as hm74a agonists

Publications (1)

Publication Number	Publication Date
BRPI0713561A2 true BRPI0713561A2 (pt)	2012-03-13

Family

ID=40839533

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0713561-0A BRPI0713561A2 (pt)	2006-06-23	2007-06-22	composto ou um sal ou pró-droga farmaceuticamente aceitável do mesmo, composição, e, métodos de modulação do receptor e de tratamento de uma doença

Country Status (3)

Country	Link
CN (1)	CN101479273B (es)
BR (1)	BRPI0713561A2 (es)
ES (1)	ES2355325T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3251675B1 (en) *	2015-01-30	2021-04-21	Shanton Pharma Pte. Ltd.	Prevention or treatment of uric acid or gout disease
CN114591247A (zh) *	2020-12-04	2022-06-07	鲁南制药集团股份有限公司	一种替莫唑胺中间体化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1092435B1 (en) *	1998-07-02	2007-04-04	Kyowa Hakko Kogyo Co., Ltd.	Remedies for diabetes
EP1251130B1 (en) *	1999-12-24	2005-02-16	Kyowa Hakko Kogyo Co., Ltd.	Fused purine derivatives

2007
- 2007-06-22 ES ES07798941T patent/ES2355325T3/es active Active
- 2007-06-22 BR BRPI0713561-0A patent/BRPI0713561A2/pt not_active IP Right Cessation
- 2007-06-22 CN CN200780022699XA patent/CN101479273B/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2355325T3 (es)	2011-03-24
CN101479273A (zh)	2009-07-08
CN101479273B (zh)	2011-11-30

Similar Documents

Publication	Publication Date	Title
CU20100062A7 (es)	2011-10-05	Derivados de pirrolo [2,3-d] pirimidina como inhibidores de proteínas quinasas b
ATE517882T1 (de)	2011-08-15	Chinolinderivate
BR112013028430A2 (pt)	2017-08-01	composto, composição farmacêutica, método para tratar uma doença ou condição mediada por tirosina quinase do baço (syk), e, uso de uma quantidade terapeuticamente eficiente do composto
MX2009000169A (es)	2009-01-26	Derivados de purinona como agonistas de hm74a.
UY32174A (es)	2010-05-31	Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
CY1118721T1 (el)	2017-07-12	Παραγωγα 2,3 διϋδρο-1η-ινδεν-1-υλ-2,7-διαζασπειρο[3.6]εννεανιου και η χρηση αυτων ως ανταγωνιστες ή αντιστροφοι αγωνιστες του υποδοχεα γκρελινης
EA201290191A1 (ru)	2012-12-28	N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
BR112012019762A2 (pt)	2016-02-23	composto, composição, e, método para tratar uma doença.
JO3265B1 (ar)	2018-09-16	مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض
EA201001196A1 (ru)	2011-02-28	Соединения 4-пиридинона и их применение для лечения рака
EA201170617A1 (ru)	2011-12-30	Пиразолиламинопиридины в качестве ингибиторов fak
EA201300052A1 (ru)	2013-06-28	[1,8]нафтиридиновые производные
DK2324008T3 (da)	2012-07-23	Diarylpyrazol som protein kinase inhibitorer
MX2012003007A (es)	2012-04-11	Sulfonamidas como inhibidores de las proteinas de la familia bcl-2 para el tratamiento de cancer.
GEP20084439B (en)	2008-07-25	Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
TN2009000180A1 (en)	2010-10-18	NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
MX2013007336A (es)	2013-08-01	Compuestos de bi-heteroarilo como inhibidores de vps34.
MX346186B (es)	2017-03-10	Inhibidores de proteina cinasas.
MX2010013682A (es)	2011-03-15	Derivados de 2,4-diamino-l,3,5-triazina triciclicos utiles para el tratamiento del cancer y trastornos mieloproliferativos.
BRPI0806789B8 (pt)	2021-05-25	composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo
EA201001747A1 (ru)	2011-08-30	Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств
BRPI0507903A (pt)	2007-07-10	derivados de quinazolina e composição farmacêutica compreendendo os mesmos
BR112012031634A2 (pt)	2016-11-08	composto, composição farmacêutica, uso de um composto, e método para tratar um paciente que sofre de ou susceptível a um distúrbio
WO2013040227A3 (en)	2013-07-25	Therapeutic compounds
TW200626158A (en)	2006-08-01	Naphthaline derivatives

Legal Events

Date	Code	Title	Description
2016-09-13	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 9A ANUIDADE.
2017-01-10	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.